Product NDC: | 0024-1800 |
Proprietary Name: | SKELID |
Non Proprietary Name: | tiludronate disodium |
Active Ingredient(s): | 200 mg/1 & nbsp; tiludronate disodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-1800 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020707 |
Marketing Category: | NDA |
Start Marketing Date: | 19970307 |
Package NDC: | 0024-1800-16 |
Package Description: | 56 TABLET in 1 CARTON (0024-1800-16) |
NDC Code | 0024-1800-16 |
Proprietary Name | SKELID |
Package Description | 56 TABLET in 1 CARTON (0024-1800-16) |
Product NDC | 0024-1800 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tiludronate disodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19970307 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | TILUDRONATE DISODIUM |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |